
Everest Biotech was founded in 2000 by a group of Biochemists at the University of Oxford. Their specialist knowledge of antibody purification and proteomics led to the development of a company committed to manufacturing high quality novel antibodies for the research market. Currently there are over 1800 antibodies listed on the catalogue, with approximately 45 new products added every month.